Valuable Role of Neutrophil CD64 and Highly Sensitive CRP Biomarkers for Diagnostic, Monitoring, and Prognostic Evaluations of Sepsis Patients in Neonatal ICUs

Table 3

Comparison between nonsurvivor sepsis patients and survivor sepsis patients.

	Nonsurvivor sepsis group	Survivor sepsis group
	Median (IQR)	Median (IQR)
GA (weeks)	34 (32.75-37)	36 (34-38)	-2.192	0.028
BW (grams)	2700 (2000-3200)	2580 (1900-3212.5)	-0.076	0.939
Hb (g/dL)	11.15 (9.8-12)	13.1 (10.675-14.8)	-3.507	<0.001
TLC (×10^9/L)	10.65 (8.15-17.8)	14.6 (9.65-19.95)	-2.17	0.03
ANC (×10^9/L)	6.5 (2.4-12.4)	7 (4.4875-12.225)	-1.11	0.267
Platelet (×10^9/L)	90 (29-168)	240 (158-321.75)	-5.252	<0.001
hs-CRP(mg/L)	24 (9.75-96)	12 (6-37)	-2.368	0.018
CD64%	94.1 (83-97.6)	81.85 (60.075-89.375)	-4.213	<0.001
CD64 MFI	2.15 (1.76-3)	1.82 (1.44-2.41)	-2.958	0.003

GA: gestational age; BW: birth weight; Hb: hemoglobin; TLC: total leukocyte count; ANC: absolute neutrophil count; PLT: platelet; hs-CRP: highly sensitive CRP; nCD64%: neutrophil CD64%; nCD64MFI: nCD64 mean fluorescence intensity.